Factors impacting COVID-19 vaccine decision making in older adults and people with underlying conditions in Victoria, Australia: A cross-sectional survey. 2022

Ruby Biezen, and Jessica Kaufman, and Monsurul Hoq, and Jo-Anne Manski-Nankervis, and Lena Sanci, and J Simon Bell, and Julie Leask, and Holly Seale, and Jane Munro, and Darren Suryawijaya Ong, and Jane Oliver, and Carol Jos, and Jane Tuckerman, and Kathleen Bagot, and Margie Danchin
Department of General Practice, University of Melbourne, Melbourne, Australia.

Australia's COVID-19 vaccine rollout included prioritizing older adults and those with underlying conditions. However, little was known around the factors impacting their decision to accept the vaccine. This study aimed to assess vaccine intentions, information needs, and preferences of people prioritized to receive the COVID-19 vaccine at the start of the Australian vaccine rollout. A cross-sectional online survey of people aged ≥70 years or 18-69 with chronic or underlying conditions was conducted between 12 February and 26 March 2021 in Victoria, Australia. The World Health Organization Behavioural and Social Drivers of COVID-19 vaccination framework and items informed the survey design and framing of results. Bivariate logistic regression was used to investigate the association between intention to accept a COVID-19 vaccine and demographic characteristics. In total, 1828 eligible people completed the survey. Intention to vaccinate was highest among those ≥70 years (89.6%, n = 824/920) versus those aged 18-69 years (83.8%, n = 761/908), with 91% (n = 1641/1803) of respondents agreeing that getting a COVID-19 vaccine was important to their health. Reported vaccine safety (aOR 1.4, 95% CI 1.1 to 1.8) and efficacy (aOR 1.9, 95% CI 1.5 to 2.3) were associated with intention to accept a COVID-19 vaccine. Concerns around serious illness, long-term effects, and insufficient vaccine testing were factors for not accepting a COVID-19 vaccine. Preferred communication methods included discussion with healthcare providers, with primary care providers identified as the most trusted information source. This study identified factors influencing the prioritized public's COVID-19 vaccine decision-making, including information preferences. These details can support future vaccination rollouts.

UI MeSH Term Description Entries
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D003657 Decision Making The process of making a selective intellectual judgment when presented with several complex alternatives consisting of several variables, and usually defining a course of action or an idea. Credit Assignment,Assignment, Credit,Assignments, Credit,Credit Assignments
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086663 COVID-19 Vaccines Vaccines or candidate vaccines containing SARS-CoV-2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent COVID-19. 2019 Novel Coronavirus Vaccine,2019 Novel Coronavirus Vaccines,2019-nCoV Vaccine,2019-nCoV Vaccines,COVID 19 Vaccine,COVID-19 Vaccine,COVID-19 Virus Vaccine,COVID-19 Virus Vaccines,COVID19 Vaccine,COVID19 Vaccines,COVID19 Virus Vaccine,COVID19 Virus Vaccines,Coronavirus Disease 2019 Vaccine,Coronavirus Disease 2019 Vaccines,Coronavirus Disease 2019 Virus Vaccine,Coronavirus Disease 2019 Virus Vaccines,Coronavirus Disease-19 Vaccine,Coronavirus Disease-19 Vaccines,SARS Coronavirus 2 Vaccines,SARS-CoV-2 Vaccine,SARS-CoV-2 Vaccines,SARS2 Vaccine,SARS2 Vaccines,2019 nCoV Vaccine,2019 nCoV Vaccines,COVID 19 Vaccines,COVID 19 Virus Vaccine,COVID 19 Virus Vaccines,Coronavirus Disease 19 Vaccine,Coronavirus Disease 19 Vaccines,SARS CoV 2 Vaccine,SARS CoV 2 Vaccines,Vaccine, 2019-nCoV,Vaccine, COVID 19,Vaccine, COVID-19,Vaccine, COVID-19 Virus,Vaccine, COVID19,Vaccine, COVID19 Virus,Vaccine, Coronavirus Disease-19,Vaccine, SARS-CoV-2,Vaccine, SARS2,Vaccines, 2019-nCoV,Vaccines, COVID-19,Vaccines, COVID-19 Virus,Vaccines, COVID19,Vaccines, COVID19 Virus,Vaccines, Coronavirus Disease-19,Vaccines, SARS-CoV-2,Vaccines, SARS2,Virus Vaccine, COVID-19,Virus Vaccine, COVID19,Virus Vaccines, COVID-19,Virus Vaccines, COVID19
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014739 Victoria A state in southeastern Australia, the southernmost state. Its capital is Melbourne. It was discovered in 1770 by Captain Cook and first settled by immigrants from Tasmania. In 1851 it was separated from New South Wales as a separate colony. Self-government was introduced in 1851; it became a state in 1901. It was named for Queen Victoria in 1851. (From Webster's New Geographical Dictionary, 1988, p1295 & Room, Brewer's Dictionary of Names, p574)
D033182 Intention What a person has in mind to do or bring about. Intentions

Related Publications

Ruby Biezen, and Jessica Kaufman, and Monsurul Hoq, and Jo-Anne Manski-Nankervis, and Lena Sanci, and J Simon Bell, and Julie Leask, and Holly Seale, and Jane Munro, and Darren Suryawijaya Ong, and Jane Oliver, and Carol Jos, and Jane Tuckerman, and Kathleen Bagot, and Margie Danchin
April 2022, Sexual health,
Ruby Biezen, and Jessica Kaufman, and Monsurul Hoq, and Jo-Anne Manski-Nankervis, and Lena Sanci, and J Simon Bell, and Julie Leask, and Holly Seale, and Jane Munro, and Darren Suryawijaya Ong, and Jane Oliver, and Carol Jos, and Jane Tuckerman, and Kathleen Bagot, and Margie Danchin
May 2022, Vaccines,
Ruby Biezen, and Jessica Kaufman, and Monsurul Hoq, and Jo-Anne Manski-Nankervis, and Lena Sanci, and J Simon Bell, and Julie Leask, and Holly Seale, and Jane Munro, and Darren Suryawijaya Ong, and Jane Oliver, and Carol Jos, and Jane Tuckerman, and Kathleen Bagot, and Margie Danchin
June 2023, SSM - population health,
Ruby Biezen, and Jessica Kaufman, and Monsurul Hoq, and Jo-Anne Manski-Nankervis, and Lena Sanci, and J Simon Bell, and Julie Leask, and Holly Seale, and Jane Munro, and Darren Suryawijaya Ong, and Jane Oliver, and Carol Jos, and Jane Tuckerman, and Kathleen Bagot, and Margie Danchin
April 2022, Vaccines,
Ruby Biezen, and Jessica Kaufman, and Monsurul Hoq, and Jo-Anne Manski-Nankervis, and Lena Sanci, and J Simon Bell, and Julie Leask, and Holly Seale, and Jane Munro, and Darren Suryawijaya Ong, and Jane Oliver, and Carol Jos, and Jane Tuckerman, and Kathleen Bagot, and Margie Danchin
January 2021, Healthcare (Basel, Switzerland),
Ruby Biezen, and Jessica Kaufman, and Monsurul Hoq, and Jo-Anne Manski-Nankervis, and Lena Sanci, and J Simon Bell, and Julie Leask, and Holly Seale, and Jane Munro, and Darren Suryawijaya Ong, and Jane Oliver, and Carol Jos, and Jane Tuckerman, and Kathleen Bagot, and Margie Danchin
August 2023, JMIR public health and surveillance,
Ruby Biezen, and Jessica Kaufman, and Monsurul Hoq, and Jo-Anne Manski-Nankervis, and Lena Sanci, and J Simon Bell, and Julie Leask, and Holly Seale, and Jane Munro, and Darren Suryawijaya Ong, and Jane Oliver, and Carol Jos, and Jane Tuckerman, and Kathleen Bagot, and Margie Danchin
October 2020, EClinicalMedicine,
Ruby Biezen, and Jessica Kaufman, and Monsurul Hoq, and Jo-Anne Manski-Nankervis, and Lena Sanci, and J Simon Bell, and Julie Leask, and Holly Seale, and Jane Munro, and Darren Suryawijaya Ong, and Jane Oliver, and Carol Jos, and Jane Tuckerman, and Kathleen Bagot, and Margie Danchin
October 2022, Vaccines,
Ruby Biezen, and Jessica Kaufman, and Monsurul Hoq, and Jo-Anne Manski-Nankervis, and Lena Sanci, and J Simon Bell, and Julie Leask, and Holly Seale, and Jane Munro, and Darren Suryawijaya Ong, and Jane Oliver, and Carol Jos, and Jane Tuckerman, and Kathleen Bagot, and Margie Danchin
October 2023, Public health,
Ruby Biezen, and Jessica Kaufman, and Monsurul Hoq, and Jo-Anne Manski-Nankervis, and Lena Sanci, and J Simon Bell, and Julie Leask, and Holly Seale, and Jane Munro, and Darren Suryawijaya Ong, and Jane Oliver, and Carol Jos, and Jane Tuckerman, and Kathleen Bagot, and Margie Danchin
January 2022, International journal of general medicine,
Copied contents to your clipboard!